ASHOK REDDY, M.D.
Ophthalmology Physician · ALBUQUERQUE, NM
Individual Active NPI 1225028228
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,334 | 54,470 | $7,389,801 | $4,285,905 | $3,370,057 |
| 2023 | 1,390 | 33,900 | $6,767,593 | $4,129,314 | $3,240,381 |
| 2022 | 1,409 | 15,440 | $6,591,059 | $4,195,673 | $3,299,100 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 45,180 | $34 | $27 |
| J0177 | Injection, aflibercept hd, 1 mg | 2,136 | $332 | $264 |
| 67028 | Injection of drug into eye | 1,731 | $119 | $87 |
| J0178 | Injection, aflibercept, 1 mg | 1,372 | $808 | $641 |
| 92134 | Imaging of retina | 1,355 | $37 | $26 |
| J2778 | Injection, ranibizumab, 0.1 mg | 556 | $163 | $128 |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 472 | $86 | $58 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 416 | $120 | $72 |
| J7999 | Compounded drug, not otherwise classified | 270 | $83 | $63 |
| J3590 | Unclassified biologics | 81 | $2,661 | $2,113 |
| 92014 | Established patient complete exam of visual system | 47 | $117 | $78 |
| 67041 | Removal of membrane of retina | 43 | $1,018 | $812 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | MD2005-0164 | NM |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in New Mexico
- NPI 1295717833
- NPI 1548226277
- NPI 1629269352
- NPI 1043370554
- NPI 1417165721
- NPI 1962417410
- NPI 1700871894
- NPI 1316937295
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.